Healthcare revenues inch past the tech space

Amy Baxter | | Health Exec | Policy & Regulations

Health insurance is big business, according to revenue reports from major players in the space. In fact, the five largest conglomerates in healthcare and pharmaceuticals are on track to outpace revenues of the five preeminent technology companies, according to Axios.

Collectively, Anthem, Cigna, CVS Health, Humana and UnitedHealth Group will likely have $787 billion in revenues in 2019, compared to $783 billion in revenues between Facebook, Amazon, Apple, Netflix and Google.

However, revenues don’t tell the whole story, and healthcare is still a tough industry. The tech companies were all more profitable––about five times more than the healthcare companies in 2018. In 2019, the tech companies are projected to be 3.5 times as profitable, according to Axios.

Still, healthcare companies are doing more than ever by expanding services and engaging in mergers and acquisitions at a rapid clip. The five largest companies in the healthcare space are expected to turn overall large profits.

See the full story below:

Health insurance is as big as Big Tech

Amy Baxter
Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Related Content

More than 1,000 hospitals earn $700M opioid crisis judgment
VA planning 83,000 layoffs as part of restructuring
HIMSS survey report: Beware insider threats to cybersecurity involving AI
HHS spokesperson abruptly resigns, reportedly after clash with RFK
Hospital faces $3.5M settlement after sharing patient data with Facebook
Philips pulls endovascular devices from market after safety issues prompt Class I recall

Around the web

Cardiovascular Business
Boston Scientific enters renal denervation market with acquisition worth up to $540M

Boston Scientific has announced another significant M&A deal, scooping up an Israeli medtech company focused on RDN technology. 

Radiology Business
Shift toward imaging outside the hospital could save billions

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Cardiovascular Business
FDA announces catheter recall for Johnson & Johnson PFA system due to stroke risk

The recall comes after approximately 3% of patients treated with the device during the early stages of its U.S. rollout experienced a stroke or transient ischemic attack following surgery. The expected stroke rate is closer to 1%, the FDA explained.